Synthesis and Antifungal Evaluation of Novel Triazole Derivatives as Inhibitors of Cytochrome P450 14α-Demethylase.

Shichong Yu,Xiaoyun Chai,Honggang Hu,Yongzheng Yan,Zhongjun Guan,Yan Zou,Qingyan Sun,Qiuye Wu

DOI: https://doi.org/10.1002/chin.201103212

2011-01-01

ChemInform

Abstract:Novel fluconazole analogues (I) are obtained via click reaction approach at which the 1,4-disubstituted regioisomers are formed exclusively in the final step.

What problem does this paper attempt to address?

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Zhongjun Guan,Xiaoyun Chai,Shichong Yu,Honggang Hu,Yuanying Jiang,Qingguo Meng,Qiuye Wu

DOI: https://doi.org/10.1111/j.1747-0285.2010.01038.x

2010-10-25

Abstract:Twenty-eight novel triazole derivatives (compounds 1a-v, 2a-f) have been synthesized for structure-activity relationship studies as antifungal agents. The compounds were designed on the basis of the structure of fluconazole and molecular modeling of the active site of the cytochrome P450 14α-demethylase (CYP51). All of them are reported for the first time. Their chemical structures are characterized by (1) H NMR, (13) C NMR, LC-MS, and elemental analysis. The antifungal activities have been evaluated in vitro by measuring the minimal inhibitory concentrations (MICs). Compounds 1a-v exhibited higher activity against nearly all fungi tested except Aspergillus fumigatus (A. fum) than fluconazole (FCZ). The computational molecular docking experiments indicated that the inhibition of CYP51 involves a coordination bond with iron of the heme group, a hydrophilic H-bonding region, a hydrophobic region, and a narrow hydrophobic binding cleft.

biochemistry & molecular biology,chemistry, medicinal
Synthesis and biological activity of novel 1,3,4-oxadiazole derivatives containing a pyrazole moiety

Wei Yu,Zhi-Wen Zhai,David E. Wedge,Stephen O. Duke,Hong-Ke Wu,Jian-Quan Weng,Cheng-Xia Tan,Yong-Gang Zhang,Xing-Hai Liu

DOI: https://doi.org/10.1007/s11164-019-04015-8

IF: 3.134

2019-01-01

Research on Chemical Intermediates

Abstract:Several new 1,3,4-oxadiazole derivatives containing a pyrazole ring were designed and synthesized from ethyl acetoacetate and triethyl orthoformate as starting materials via multi-step reactions. The compound structures were confirmed by melting point, 1 H NMR and HRMS. They were evaluated for fungicidal and herbicidal activities. Four of the compounds exhibited moderate fungicidal activity against Colletotrichum species. Most of the compounds had moderate-to-good activity as a herbicide.
Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

Xian-Fu Fang,Di Li,Vijai Kumar Reddy Tangadanchu,Lavanya Gopala,Wei-Wei Gao,Cheng-He Zhou

DOI: https://doi.org/10.1016/j.bmcl.2017.10.020

IF: 2.94

2017-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A series of novel potentially antifungal hybrids of 5-flucytosine and fluconazole were designed, synthesized and characterized by 1H NMR, 13C NMR, IR and HRMS spectra. Bioactive assay manifested that some prepared compounds showed moderate to good antifungal activities in comparison with fluconazole and 5-flucytosine. Remarkably, the 3,4-dichlorobenzyl hybrid 7h could inhibit the growth of C. albicans ATCC 90023 and clinical resistant strain C. albicans with MIC values of 0.008 and 0.02 mM, respectively. The active molecule 7h could not only rapidly kill C. albicans but also efficiently permeate membrane of C. albicans. Molecular docking study revealed that compound 7h could interact with the active site of CACYP51 through hydrogen bond. Quantum chemical studies were also performed to explain the high antifungal activity. Further preliminary mechanism research suggested that molecule 7h could intercalate into calf thymus DNA to form a steady supramolecular complex, which might block DNA replication to exert the powerful bioactivities.
Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Yumeng Hao,Ruina Wang,Tingjunhong Ni,Brian C Monk,Joel D A Tyndall,Junhe Bao,Mengyuan Wang,Xiaochen Chi,Shichong Yu,Yongsheng Jin,Dazhi Zhang,Lan Yan,Fei Xie

DOI: https://doi.org/10.1016/j.ejmech.2024.116637

2024-09-05

Abstract:Life-threatening invasive fungal infections pose a serious threat to human health. A series of novel triazole derivatives bearing a pyrazole-methoxyl moiety were designed and synthesized in an effort to obtain antifungals with potent, broad-spectrum activity that are less susceptible to resistance. Most of these compounds exhibited moderate to excellent in vitro antifungal activities against Candida albicans SC5314 and 10,231, Cryptococcus neoformans 32,609, Candida glabrata 537 and Candida parapsilosis 22,019 with minimum inhibitory concentration (MIC) values of ≤0.125 μg/mL to 0.5 μg/mL. Use of recombinant Saccharomyces cerevisiae strains showed compounds 7 and 10 overcame the overexpression and resistant-related mutations in ERG11 of S. cerevisae and several pathogenic Candida spp. Despite being substrates of the C. albicans and Candida auris Cdr1 drug efflux pumps, compounds 7 and 10 showed moderate potency against five fluconazole (FCZ)-resistant fungi with MIC values from 2.0 μg/mL to 16.0 μg/mL. Growth kinetics confirmed compounds 7 and 10 had much stronger fungistatic activity than FCZ. For C. albicans, compounds 7 and 10 inhibited the yeast-to-hyphae transition, biofilm formation and destroyed mature biofilm more effectively than FCZ. Preliminary mechanism of action studies showed compounds 7 and 10 blocked the ergosterol biosynthesis pathway at Erg11, ultimately leading to cell membrane disruption. Further investigation of these novel triazole derivatives is also warranted by their predicted ADMET properties and low cytotoxicity.
Design, Synthesis and Molecular Docking Studies of Novel Triazole Antifungal Compounds

Qiu Qin He,Ke Li,Yong Bing Cao,Huan Wen Dong,Li Hua Zhao,Chao Mei Liu,Chun Quan Sheng

DOI: https://doi.org/10.1016/j.cclet.2007.04.025

2007-01-01

Abstract:Based on the active site of Candida albicans lanosterol 14α-demethylase (CACYP51), novel triazole compounds structurally different from the current triazole drugs were designed and synthesized. In vitro antifungal activities showed that compounds 10, 11, 16 and 20 exhibited strong activities. In addition, compounds 10, 11 and 16 also displayed certain activities against fluconazole-resistant fungi.
Design,Synthesis and Antifungal Activity of Novel Pyrazole-Thiophene Carboxamide Derivatives

Anbang Li,Zhongshan Li,Yang Zhao,Tingting Yao,Jingli Cheng,Jinhao Zhao

DOI: https://doi.org/10.6023/cjoc202004013

2020-01-01

Abstract:Succinate dehydrogenase inhibitor is a low-toxic and high active fungicide. In order to develop novel and broad-spectrum succinate dehydrogenase inhibitor (SDHI) fungicides, thiophene was introduced into the structure of pyrazole carboxamide fungicides. Twenty four pyrazole-thiophene carboxamides were designed, synthesized and characterized by H NMR, C NMR and HRMS. The crystal structure of N-(4-methoxyphenyl)-4-(1-methyl-1H-pyrazol-4-yl)thiophene2-carboxamide (7i) was determined by X-ray diffraction. The antifungal activity of all the synthesized compounds was determined against six plant pathogenic fungi, and preliminary bioassays suggested that some compounds exhibited good antifungal activity against Rhizoctonia solani, Fusarium graminearum and Botrytis cinerea. Among them, N-(4fluorophenethyl)-4-(1-methyl-1H-pyrazol-4-yl)thiophene-2-carboxamide (7c) exhibited the best antifungal activities against R. solani in vitro with EC50 value of 11.6 μmol/L, and N-(2-fluorophenyl)-4-(1-methyl-1H-pyrazol-4-yl)thiophene-2-carboxamide (7j) against F. graminearum with EC50 value of 28.9 μmol/L. And N-(4-chlorophenyl)-4-(1-methyl-1H-pyrazol-4yl)thiophene-2-carboxamide (7h) showed similar inhibition abilities with thifluzamide against B. cinerea with EC50 value of 21.3 μmol/L. The molecular docking results showed that the high antifungal activitie compounds form stronger interactions with important amino acid residues of succinate dehydrogenase.
Design, synthesis, antifungal evaluation, and molecular docking of novel 1,2,4-triazole derivatives containing oxime ether and cyclopropyl moieties as potential sterol demethylase inhibitors

Sheng-Xin Sun,Jing-Hua Yan,Jiang-Tao Zuo,Xiao-Bin Wang,Min Chen,Ai-Min Lu,Chun-Long Yang,Guo-Hua Li

DOI: https://doi.org/10.1039/d1nj03578a

IF: 3.3

2021-01-01

New Journal of Chemistry

Abstract:A series of novel triazole derivatives containing oxime ether and cyclopropyl moieties were designed and synthesized. Some compounds exhibited remarkable antifungal activities. The molecular docking of compound 5k with Fg CYP51 was investigated.

chemistry, multidisciplinary
Synthesis, antifungal activity and molecular docking of (E) -3- ( ( (1, 3, 4-thiadiazol-2-yl) amino) methylene) -thiochroman-4-ones

Sheng-bin LI,Hui QI,Chao-chao ZHANG,Zhen-ming LIU,Ya-li SONG,Xiao-qiang QIAO

DOI: https://doi.org/10.16438/j.0513-4870.2018-0310

2018-01-01

Abstract:Thiochromanones and 1, 3, 4-thiadazoles as heterocyclic compounds have broad biological activities. In order to find novel compounds with antifungal activity, we synthesized a novel series of (E) -3- ( ( (1, 3, 4-thiadiazol-2-yl) amino) methylene) -thiochroman-4-ones. Structures of these compounds were established by HR-MS, 1 H NMR, 13 C NMR and 1 D-noesy. All of the synthesized compounds were screened for antifungal activity by using an established agar double dilution method (plate method) against ten fungi species in vitro. Compound 5 j showed significant inhibitory activity to Colletotrichum capsici, Rhizoctonia cerealis and Aspergillus niger compared with that of the positive control carbendazim. Compounds 5 h exhibited better antifungal activity to Canidia albicans and Aspergillus funigatus than the positive control fluconazole, in which the minimum inhibition concentration can reach 8 μg·m L-1 and 16 μg·m L-1. Moreover, the molecular docking method was used to study the interaction mode of compound 5 h and CYP51, and the results will be helpful for designing of CYP51 inhibitors in the future.
Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Junhe Bao,Yumeng Hao,Tingjunhong Ni,Ruina Wang,Jiacun Liu,Xiaochen Chi,Ting Wang,Shichong Yu,Yongsheng Jin,Lan Yan,Xiaomei Li,Dazhi Zhang,Fei Xie

DOI: https://doi.org/10.1080/14756366.2023.2244696

2023-08-10

Journal of Enzyme Inhibition and Medicinal Chemistry

Abstract:A series of novel triazole derivatives containing aryl-propanamide side chains was designed and synthesised. In vitro antifungal activity studies demonstrated that most of the compounds inhibited the growth of six human pathogenic fungi. In particular, parts of phenyl-propionamide-containing compounds had excellent, broad-spectrum antifungal activity against Candida albicans SC5314, Cryptococcus neoformans 22-21, Candida glabrata 537 and Candida parapsilosis 22-20 with MIC values in the range of ≤0.125 μg/mL–4.0 μg/mL. In addition, compounds A1 , A2 , A6 , A12 and A15 showed inhibitory activities against fluconazole-resistant Candida albicans and Candida auris . Preliminary structure-activity relationships (SARs) are also summarised. Moreover, GC-MS analysis demonstrated that A1 , A3 , and A9 interfered with the C. albicans ergosterol biosynthesis pathway by inhibiting Cyp51. Molecular docking studies elucidated the binding modes of A3 and A9 with Cyp51. These compounds with low haemolytic activity and favourable ADME/T properties are promising for the development of novel antifungal agents.

biochemistry & molecular biology,chemistry, medicinal
Discovery of Novel Tetrazoles Featuring a Pyrazole Moiety as Potent and Highly Selective Antifungal Agents

Xiaochen Chi,Haonan Zhang,Hao Wu,Xianru Li,Liping Li,Yuanying Jiang,Tingjunhong Ni

DOI: https://doi.org/10.1021/acsomega.3c01421

IF: 4.1

2023-05-03

ACS Omega

Abstract:In pursuit of developing novel azole antifungals with potent activity and high selectivity, a series of (2R,3S)-3-(substituted-1H-pyrazol-3-yl)-2-(2,4-difluorophenyl)-1-(1H-tetrazol-1-yl)butan-2-ol derivatives were designed and synthesized based on our previous work. All compounds exhibited excellent in vitro antifungal activities against Candida spp. and Cryptococcus neoformans H99 with minimum inhibitory concentration values ranging from <0.008 to 4 μg/mL, with some even showing moderate activity against Aspergillus fumigatus 7544. The most active compounds (8, 11, 15, 24, and 25) displayed outstanding antifungal activity against six fluconazole-resistant C. auris clinical isolates and showed a potent inhibitory effect on biofilm formation of C. albicans SC5314 and C. neoformans H99. In addition, compounds 11 and 15 showed no inhibition of human CYP1A2 and low inhibitory activity against CYP3A4, indicating minimal risk of drug-drug interactions. Taken together, these promising tetrazoles with high in vitro potency and good safety profiles warrant further investigation.

chemistry, multidisciplinary
Design, Synthesis, and Antifungal Activity of Novel Thiochromanone Derivatives Containing 1,3,4-Oxadiazole Skeleton

Xiaoyang Sun,Jiajia Feng,Shengbin Li,Siran Feng,Zhenming Liu,Yali Song,Xiaoqiang Qiao

DOI: https://doi.org/10.6023/cjoc201808016

2019-01-01

Chinese Journal of Organic Chemistry

Abstract:Following the principle of union of active group, the thiochromanone was combined with 1,3,4-oxadiazole, and 12 compounds were designed and synthesized. The target compounds were confirmed by H-1 NMR and HRMS. The preliminary antifungal activity assay showed that most of the target compounds exhibited significant inhibition activity against four animal pathogenic fungi and four plant pathogenic fungi. Among them, the minimum inhibitory concentration (MIC) value of compound 4f against Canidia albicans reached 4 mu g.mL(-1), and the MIC value of 4d against Aspergillusnigervan tiegh reached 8 mu g.mL(-1), which were higher than the positive controls. And the molecular docking studies have found that 4f has strong binding ability to CYP51 of Canidia albicans, which may be a potential CYP51 inhibitor.
Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains

Fei Xie,Yumeng Hao,Junhe Bao,Jiacun Liu,Yu Liu,Ruina Wang,Xiaochen Chi,Xiaoyun Chai,Ting Wang,Shichong Yu,Yongsheng Jin,Lan Yan,Dazhi Zhang,Tingjunhong Ni

DOI: https://doi.org/10.1016/j.bioorg.2022.106216

IF: 5.307

2022-12-01

Bioorganic Chemistry

Abstract:In order to develop new triazole derivatives, we optimized the lead compound a6 by structural modifications to obtain a series of (2R,3R)-3-((1-substituted-1H-1,2,3-triazol-4-yl) methoxy)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol, compounds 5-36. Most of the target compounds exhibited excellent in vitro antifungal activity against Candida albicans 10231 and Candida glabrata 537 with MIC ≤ 0.125 µg/mL. Of particular note, compounds 6, 22, 28, 30 and 36 were highly active against Candida neoformans 32609 with MIC ≤ 0.125 µg/mL and showed broad-spectrum antifungal activity including against fluconazole-resistant Candida auris 891. In addition, compounds 6 and 22 demonstrated inhibitory effects on filamentation in the azole-resistant C. albicans isolate. Moreover, compounds 6 and 22 were minimally toxic to HUVECs and possessed weak inhibitory effects on the human CYP3A4 and CYP2D6. SARs and docking study further indicated that ortho-substituted groups in the terminal phenyl ring can promote the compounds to improve their antifungal activity.

biochemistry & molecular biology,chemistry, organic
Design, synthesis and bioactivity evaluation of triazole antifungal drugs with phenylthiophene structure

Xudong Wu,Jiachen Zhang,Rongrong Liu,Yixiang Sun,Zixuan Gao,Guoqi Zhang,Zirui Luo,Kejian Li,Qiaohua Qin,Nian Liu,Haoyu Zhang,Xin Su,Dongmei Zhao,Maosheng Cheng

DOI: https://doi.org/10.1016/j.bioorg.2024.107785

2024-09-06

Abstract:Invasive fungal infections have high morbidity and mortality rates and have become one of the most serious threats to human health. In the present study, a series of triazole antifungal derivatives with phenylthiophene backbone were obtained by structural modification of the lead compound using Iodiconazole as the lead compound. Among them, compound 19g is a triazole antifungal compound with 4-chloro-2-fluoro phenylthiophene backbone, which showed optimal antifungal activity against Candida albicans, Cryptococcus neoformans, and Aspergillus, with a MIC80 value of 0.0625 μg/mL. In addition, compounds 19e, 19f, 19g, 19h, 19i and 19k exhibited different levels of inhibitory activity against fluconazole-resistant strains with MIC80 values ranging from 0.0625 μg/mL to 32 μg/mL. Since compound 19g had optimal in vitro antifungal activity, we selected 19g for human liver microsomal stability and CYP enzyme inhibition assays as well as further evaluated the inhibitory activity of compound 19g on normal and cancerous cells in humans. Finally, we verified the inhibitory effect of compound 19g on the filamentation of Candida albicans and determined the mechanism of action by sterol composition analysis.
Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Zhigan Jiang,Julin Gu,Chen Wang,Shengzheng Wang,Na Liu,Yan Jiang,Guoqiang Dong,Yan Wang,Yang Liu,Jianzhong Yao,Zhenyuan Miao,Wannian Zhang,Chunquan Sheng

DOI: https://doi.org/10.1016/j.ejmech.2014.05.079

IF: 7.088

2014-01-01

European Journal of Medicinal Chemistry

Abstract:Due to increasing incidence of invasive fungal infections and severe drug resistance to triazole antifungal agents, a series of novel antifungal triazoles with substituted triazole-piperidine side chains were designed and synthesized. Most of the target compounds showed good inhibitory activity against a variety of clinically important fungal pathogens. In particular, compounds 8t and 8v were highly active against Candida albicans and Cryptococcus neoformans with MIC values in the range of 0.125 μg/mL to 0.0125 μg/mL. They represent promising leads for the development of new generation of triazole antifungal agents. Molecular docking studies revealed that the target compounds interacted with CACYP51 mainly through hydrophobic and Van der Waals interactions.
New Triazole Derivatives Containing Substituted 1,2,3-Triazole Side Chains: Design, Synthesis and Antifungal Activity

Hai-Jiang Chen,Yaling Jiang,Yongqiang Zhang,Qiwei Jing,Na Liu,Yan Wang,Wannian Zhang,Chunquan Sheng

DOI: https://doi.org/10.1016/j.cclet.2016.11.027

2017-01-01

Abstract:In order to discover new generation of triazole antifungal agents, a series of novel antifungal triazoles were designed and synthesized by structural simplification of our previously identified triazole-piperdine-heterocycle lead compounds. Several target compounds showed good antifungal activity with a broad spectrum. In particular, compound 7l was highly active against Candida albicans and Candida glabrata. Moreover, compound 7l showed potent in vivo antifungal efficacy in the Caenorhabditis elegans–C. albicans infection model.
Design and synthesis of spiro[pyrrolidine-3,3'-quinoline]-2,2'-dione derivatives as novel antifungal agents targeting chitin synthase

Yan Long,Xinglong Yang,Yajie Xu,Lige Liu,Nan Wang,Yiwen Chu,Junfeng Deng,Qingggang Ji

DOI: https://doi.org/10.1016/j.ejmech.2024.116895

2024-12-05

Abstract:A novel spiro [pyrrolidine-3',3'-quinoline]-2,2'-dione scaffold was constructed using fragments of quinoline and pyrrolidine. Subsequently, two series of derivatives were designed based on this scaffold. The enzyme inhibition experiments revealed that all designed compounds had moderate to good inhibitory activity against chitin synthase (CHS). The inhibitory effects of compounds 5i, 5j, 8i and 8n were approximately equal to that of control drug polyoxin B (PB, IP = 86.4 ± 2.9 %, IC50 = 0.082 ± 0.013 mM) which is a well-established CHS inhibitor. The results from enzyme kinetic parameters assays proved that these compounds act as non-competitive inhibitors of CHS. The sorbitol protection experiments demonstrated the tested compounds disrupted the synthesis of cell wall, which further verified that the target of these compounds is CHS. The experiments of antimicrobial showed that compounds 5b, 5f, 5i, 5j, 8f, 8i, 8m, 8n and 8o had strong antifungal activity against the four tested pathogenic fungi strains frequently emerging in clinical setting, with MIC values ranging from 4 to 32 μg/mL, which were either superior to or comparable with those of PB or fluconazole. Furthermore, these compounds displayed synergistic or additive effects when combined with fluconazole and these active compounds also showed promising activity against fluconazole-resistant and micafungin-resistant fungi variants. The result of antimicrobial experiments indicated that these compounds had minimal activity to tested bacterial strains. This suggests that they had selective antifungal activity. The results of ADME prediction, in conjunction with the cytotoxicity assay results, indicated that these compounds had favorable pharmacokinetic profiles and low toxicity. In addition, molecular docking studies illustrated that the compound had a strong affinity with the CHS, which was consistent with the results of enzymatic assays. These findings indicated that the designed compounds are non-competitive inhibitors of CHS with good selectivity and broad-spectrum antifungal activity, and possess significant antifungal activity against drug-resistant fungi, suggesting their potential as lead compounds for the development of novel drugs against drug-resistant fungi.
Design, Synthesis and Antifungal Activities of Novel Pyrazole Analogues Containing the Aryl Trifluoromethoxy Group

Tongchao Zhao,Yuyao Sun,Yufei Meng,Lifang Liu,Jingwen Dai,Guoan Yan,Xiaohong Pan,Xiong Guan,Liyan Song,Ran Lin

DOI: https://doi.org/10.3390/molecules28176279

IF: 4.6

2023-08-29

Molecules

Abstract:On the basis of the three-component synthetic methodology developed by us, a total of twenty-six pyrazole compounds bearing aryl OCF3 were designed and synthesized. Their chemical structures were characterized by 1H and 13C nuclear magnetic resonance and high-resolution mass spectrometry. These compounds were evaluated systematically for antifungal activities in vitro against six plant pathogenic fungi by the mycelium growth rate method. Most of the compounds showed some activity against each of the fungi at 100 μg/mL. Compounds 1t and 1v exhibited higher activity against all the tested fungi, and 1v displayed the highest activity against F. graminearum with an EC50 value of 0.0530 μM, which was comparable with commercial pyraclostrobin. Structure–activity relationship analysis showed that, with respect to the R1 substituent, the straight chain or cycloalkyl ring moiety was a key structural moiety for the activity, and the R2 substituent on the pyrazole ring could have significant effects on the activity. Simple and readily available pyrazoles with potent antifungal activity were obtained, which are ready for further elaboration to serve as a pharmacophore in new potential antifungal agents.

chemistry, multidisciplinary,biochemistry & molecular biology
Synthesis of Some Novel Hydrazone Derivatives as Antifungal Agents

Qiao Wang,Yan-Xia Shi,Ming-Yan Yang,Zhao-Hui Sun,Jian-Quan Weng,Cheng-Xia Tan,Xing-Hai Liu,Bao-Ju Li

2016-01-01

Journal of the chemical society of pakistan

Abstract:A series of novel 2-(substituted-2-benzylidenehydrazinyl)-3-chloropyridine derivatives were designed and synthesized from 2,3-dichloropyridine as starting materials, and their structures were confirmed by H-1 NMR, MS and elemental analysis. The antifungal activity of title compounds was determined. The antifungal assay showed that some of title compounds displayed excellent activity, especially against Stemphylium lycopersici (Enjoji) Yamamoto and Fusarium oxysporum. sp. cucumebrium.
Synthesis, Structural Determination, and Antifungal Activity of Novel Fluorinated Quinoline Analogs

Xinpeng Sun,Wei Yu,Lijing Min,Liang Han,Xuewen Hua,Jianjun Shi,Nabo Sun,Xinghai Liu

DOI: https://doi.org/10.3390/molecules28083373

IF: 4.6

2023-04-12

Molecules

Abstract:A series of new fluorinated quinoline analogs were synthesized using Tebufloquin as the lead compound, 2-fluoroaniline, ethyl 2-methylacetoacetate, and substituted benzoic acid as raw materials. Their structures were confirmed by 1H NMR, 13C NMR, and HRMS. The compound 8-fluoro-2,3-dimethylquinolin-4-yl 4-(tert-butyl)benzoate (2b) was further determined by X-ray single-crystal diffraction. The antifungal activity was tested at 50 μg/mL, and the bioassay results showed that these quinoline derivatives had good antifungal activity. Among them, compounds 2b, 2e, 2f, 2k, and 2n exhibited good activity (>80%) against S. sclerotiorum, and compound 2g displayed good activity (80.8%) against R. solani.

chemistry, multidisciplinary,biochemistry & molecular biology
Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents

Tingjunhong Ni,Xiaochen Chi,Fei Xie,Liping Li,Hao Wu,Yumeng Hao,Xiaobo Wang,Dazhi Zhang,Yuanying Jiang

DOI: https://doi.org/10.1016/j.ejmech.2022.115007

IF: 7.088

2022-12-07

European Journal of Medicinal Chemistry

Abstract:In an effort to develop novel azole antifungals with potent activity and high selectivity, a series of (2 R ,3 R )-3-((3-substitutied-phenyl-isoxazol-5-yl)methoxy)-2-(2,4-difluorophenyl)-1-(1 H -tetrazol-1-yl)butan-2-ol derivatives were designed and synthesized based on our previously work. All compounds exhibited moderate to excellent in vitro antifungal activities against Candida albicans SC5314 and Cryptococcus neoformans H99, but inactive against Aspergillus fumigatus 7544. Among them, the most active compound 10h displayed outstanding antifungal activity against fluconazole-resistant C. albicans 103, C. glabrata 537 and C. auris 922 with MIC values of ≤0.008 μg/mL. In addition, compound 10h was superior to FLC in inhibiting the filamentation of FLC-resistant C. albicans 103. Notably, compound 10h showed no inhibition of human CYP3A4 with IC 50 values of >100 μM, low cytotoxicity at 32 μg/mL and low hERG inhibition with IC 50 values of 6.22 μM, suggesting a low risk of drug-drug interactions and good safety profiles. Furthermore, compound 10h exhibited excellent PK profiles and showed remarkable in vivo efficacy in a mouse model of C. albicans and C. neoformans infection. Taken together, compound 10h will be further investigated as a promising lead antifungal agent.

chemistry, medicinal

Synthesis and Antifungal Evaluation of Novel Triazole Derivatives as Inhibitors of Cytochrome P450 14α-Demethylase.

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Synthesis and biological activity of novel 1,3,4-oxadiazole derivatives containing a pyrazole moiety

Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design, Synthesis and Molecular Docking Studies of Novel Triazole Antifungal Compounds

Design,Synthesis and Antifungal Activity of Novel Pyrazole-Thiophene Carboxamide Derivatives

Design, synthesis, antifungal evaluation, and molecular docking of novel 1,2,4-triazole derivatives containing oxime ether and cyclopropyl moieties as potential sterol demethylase inhibitors

Synthesis, antifungal activity and molecular docking of (E) -3- ( ( (1, 3, 4-thiadiazol-2-yl) amino) methylene) -thiochroman-4-ones

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Discovery of Novel Tetrazoles Featuring a Pyrazole Moiety as Potent and Highly Selective Antifungal Agents

Design, Synthesis, and Antifungal Activity of Novel Thiochromanone Derivatives Containing 1,3,4-Oxadiazole Skeleton

Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains

Design, synthesis and bioactivity evaluation of triazole antifungal drugs with phenylthiophene structure

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

New Triazole Derivatives Containing Substituted 1,2,3-Triazole Side Chains: Design, Synthesis and Antifungal Activity

Design and synthesis of spiro[pyrrolidine-3,3'-quinoline]-2,2'-dione derivatives as novel antifungal agents targeting chitin synthase

Design, Synthesis and Antifungal Activities of Novel Pyrazole Analogues Containing the Aryl Trifluoromethoxy Group

Synthesis of Some Novel Hydrazone Derivatives as Antifungal Agents

Synthesis, Structural Determination, and Antifungal Activity of Novel Fluorinated Quinoline Analogs

Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents